Overview
- Judge Ernesto Kreplak froze assets and barred 24 suspects from travel as seized contaminated ampoules were removed from circulation.
- Health Minister Mario Lugones opened an internal ANMAT/INAME inquiry and publicly accused HLB Pharma owner Ariel García Furfaro of enjoying political protection.
- Forensic teams from ANLIS Malbrán and the Supreme Court medical corps are preparing genomic and clinical analyses to definitively link December 2024 lots to patient infections.
- An anonymous former HLB Pharma employee alleged systemic falsification of quality-control records and that ANMAT inspectors received advance notice of audits.
- Investigators located additional contaminated ampoules in Córdoba and Chubut, underscoring traceability gaps and leaving thousands of doses unaccounted for.